Culture medium and culture method for gastric cancer organoid

By providing specific gastric cancer cell culture medium and culture methods, the cumbersome and cost-effective problems of gastric cancer tumor organoid culture in the prior art are solved, the success rate and survival rate of gastric cancer cells are improved, the primary tissue characteristics are maintained, and the primary tissue characteristics are promoted The expression of the target protein is suitable for individualized and accurate research on gastric cancer.

CN118995619APending Publication Date: 2024-11-22BAORUIJIN (JILIN) BIOTECHNOLOGY CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411479029.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-23
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

In the prior art, the cultivation method of gastric cancer tumor organoids is complicated to operate, has a long time and is costly, and the obtained tumor organs are very different from the organs of the patient themselves, making it difficult to accurately reflect the biological characteristics of the early primitive tumors and affect the treatment effect.

Method used

Provide a gastric cancer cell culture medium including basal culture medium, culture factor and nutritional factor, and a culture method combining specific formulas and steps, including digestive fluid treatment of collagenase and hyaluronidase, trypsin digestion and other steps. The culture conditions are 37°C, 5% CO2, pH 8.0-8.5, 10% bovine serum and specific proportions of culture and nutritional factors.

Benefits of technology

Improve the success rate and survival rate of gastric cancer cells, maintain the morphological structure and genetic characteristics of the primary tissue, reduce the risk of microbial contamination, and cultivate various pathological types of gastric cancer or metastatic lesions, which significantly promote the expression of target proteins. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995619A_ABST
    Figure CN118995619A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of biological medicine, and particularly provides a culture medium and a culture method for gastric cancer organoid, and the culture medium comprises a basic culture medium, culture factors, nutritional factors and 10% bovine serum. The culture medium is scientific in component proportion, pollution is remarkably reduced in an alkaline environment with the pH value of 8.0-8.5, and the culture success rate is increased. Cells maintain original characteristics, and gastric cancer pathological research and treatment are assisted.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biomedicine technology, and further relates to the field of using cell lines to cultivate organoids in vitro for early clinical trials of inflammatory drugs and gastric cancer drugs, and particularly to a culture medium and a culture method for gastric cancer organoids. Background Art

[0002] Gastric cancer is one of the common malignant tumors with high morbidity and mortality, ranking fourth among all malignant tumors, with a mortality rate of 22.0%. Gastric cancer has a high recurrence and metastasis rate, and more than 50% of gastric cancer patients will experience varying degrees of recurrence and metastasis within months to years after radical treatment. In recent years, gastric cancer is showing a trend of younger patients due to age and changes in lifestyle.

[0003] At present, humans still know very little about this disease. The causes of gastric cancer are complex, and the most common causes include Helicobacter pylori infection, precancerous lesions, or genetic factors, or changes in environmental and dietary factors. This type of disease has strong individual differences, and the cause, course of disease development, and treatment methods cannot be generalized.

[0004] Clinically, the treatment of gastric cancer is still mainly surgery, supplemented by radiotherapy and chemotherapy to consolidate the treatment effect. In addition, there are traditional Chinese medicine treatment and biological treatment methods. Although great progress has been made in the comprehensive treatment of gastric cancer, the cure rate of the disease has not been significantly alleviated. Therefore, using gastric cancer solid tumor primary cell culture as a model for individualized precision research is of great significance and value for the prevention and treatment of gastric cancer.

[0005] CN 110408595A discloses a method for culturing 3D tumor organoids (PDO) for testing the sensitivity of gastric cancer anti-tumor drugs. The method is complicated to operate and takes a long time to culture.

[0006] CN109182271A constructs a human gastric cancer transplant tumor model with normal immune mice, including: taking gastric cancer tumor cells, culturing with DMEM complete culture medium with fetal bovine serum, passaging, incubating, and implanting into mice for 20-30 days to complete the construction. The method uses an animal model, and the research cost is high and the research cycle is long.

[0007] It can be seen that the technology for preparing gastric cancer tumor organoids has been disclosed in the prior art, but whether the biological mechanism of the obtained tumor organ is significantly different from the patient's own organ, whether it can retain the pathological morphology of the patient's tissue, accurately reflect the behavior of the early original tumor, and truly reflect the biological characteristics of the tumor in terms of tumor genetic development, invasion, metastasis, etc., as well as the cost, difficulty, and modeling success rate of the preparation method, directly affect people's breakthrough in the bottleneck of gastric cancer treatment. Summary of the invention

[0008] In view of the shortcomings of the prior art, the present invention provides a culture medium for gastric cancer cells and a culture method thereof. The culture medium is used to culture gastric cancer cells, which can maintain the morphological structure and gene characteristics of the primary tissue and improve the success rate and survival rate of gastric cancer cell culture.

[0009] To achieve the above object, the present invention provides the following technical solutions: The invention provides a culture medium and a culture method for gastric cancer organoids. The culture medium comprises: a basic culture medium, culture factors, nutritional factors and 10% bovine serum.

[0010] The basic culture medium is Advanced DME / F12.

[0011] The culture factors include the following components and their contents: 1-3×GlutaMax, 1-3×HEPES, 1-3×P / S, 5-10%Noggin, 1-3×B27, 300-500ng / mL NA, 1-5mM N-acetylcysteine, 1-3nM gastrin, 2-6μMA83-01, 7-16μM Y-27632, 1-6g / ul primocin, and 1-3×insulin.

[0012] The nutritional factors include the following components and their contents: 30-70% Wnt3a, 30-70ng / mL EGF, 100-500ng / mL FGF10, 300-500ng / mL BFGF, 5-15% RSPO-1, and 300-500ng / mL BDNF.

[0013] The pH value of the culture medium is 8.0-8.5.

[0014] The present invention provides a culture medium and a culture method for gastric cancer organoids, wherein the culture method comprises the following steps: Step 1: Liquid preparation: To prepare digestion solution, mix collagenase and hyaluronidase in basal medium.

[0015] Prepare complete medium by adding culture factors, nutrient factors and bovine serum to basal medium, the composition of which is based on a specific formula.

[0016] Step 2 Separation: Gastric cancer biopsy tissues were preserved in Advanced DME / F12 solution containing 2% double antibody.

[0017] Gastric cancer biopsy tissue is processed, including washing, cutting and enzymatic digestion, to isolate pure cells.

[0018] The cells were mixed with Matrigel and placed in a culture plate to solidify, followed by the addition of complete medium for culture. The medium was monitored and replaced as appropriate to generate gastric cancer cells.

[0019] Step 3 Cultivation: Gastric cancer cells were taken from a centrifuge tube, rinsed with PBS, and the monolayer cells were digested with trypsin digestion solution. After the digestion reaction, the centrifuge tube was centrifuged, the supernatant was removed, and the cells were inoculated into a culture flask containing complete culture medium. The culture conditions were 37°C and 5% CO2 for 4-5 days to obtain primary gastric cancer cells.

[0020] Step 4: Passaging Take the cultured cells from the centrifuge tube, repeat the above step 3, and continuously subculture to obtain a sufficient number of gastric cancer cell subculture cells that maintain a good growth state for further experiments or research.

[0021] The culture medium and culture method of gastric cancer organoids provided by the present invention have the following beneficial effects: Gastric cancer cells are cultured in the culture medium of the present invention. The composition of the culture medium is simple and the combination is reasonable. In an alkaline environment, that is, an environment with a pH value of 8.0-8.5, the risk of microbial contamination is effectively reduced and the success rate of gastric cancer cell culture is improved. Gastric cancer cells maintain their original morphological structure and characteristics, which is of great help to the pathological research and treatment of the disease. Tumor tissues derived from primary gastric cancer can be cultured, including various pathological types of gastric cancer or gastric cancer metastatic lesions.

[0022] In order to make the purpose, technical solution and beneficial effects of the present invention clearer, the present invention provides the following drawings for illustration: Figure 1 This is a microscope image of the cell status on the first day of culture in Example 4 of the present invention; Figure 2 This is a microscope image of the cell status on the second day of culture in Example 4 of the present invention; Figure 3 This is a microscope image of the cell status on the third day of culture in Example 4 of the present invention; Figure 4 This is a microscope image of the cell status on the 5th day of culture in Example 4 of the present invention. DETAILED DESCRIPTION

[0023] The present invention is further described below in conjunction with the accompanying drawings and specific embodiments so that those skilled in the art can better understand the present invention and implement it, but the embodiments are not intended to limit the present invention.

[0024] Example 1

[0025] A culture medium and a culture method for gastric cancer organoids, the culture medium comprising: a basic culture medium, culture factors, nutritional factors and 10% bovine serum.

[0026] The basic culture medium is Advanced DME / F12.

[0027] The culture factors include the following components and their contents: 2×GlutaMax, 3×HEPES, 1×P / S, 6%Noggin, 2×B27, 300ng / mL NA, 2mM N-acetylcysteine, 1nM gastrin, 5μM A83-01, 9μM Y-27632, 2g / μL primocin, and 1×insulin.

[0028] The nutritional factors include the following components and their contents: 36% Wnt3a, 35ng / mL EGF, 150ng / mL FGF10, 300ng / mL BFGF, 7% RSPO-1, and 300ng / mL BDNF.

[0029] The pH value of the culture medium is 8.3.

[0030] Example 2

[0031] A culture medium and a culture method for gastric cancer organoids, the culture medium comprising: a basic culture medium, culture factors, nutritional factors and 10% bovine serum.

[0032] The basic culture medium is Advanced DME / F12.

[0033] The culture factors include the following components and their contents: 1×GlutaMax, 2×HEPES, 2×P / S, 10% Noggin, 2×B27, 350 ng / mL NA, 1 mM N-acetylcysteine, 1 nM gastrin, 2 μM A83-01, 10 μM Y-27632, 1 g / μL primocin, and 1×insulin.

[0034] The nutritional factors include the following components and their contents: 70% Wnt3a, 50 ng / mL EGF, 200 ng / mL FGF10, 330 ng / mL BFGF, 14% RSPO-1, and 400 ng / mL BDNF.

[0035] The pH value of the culture medium is 8.1.

[0036] Example 3

[0037] A culture medium and a culture method for gastric cancer organoids, the culture medium comprising: a basic culture medium, culture factors, nutritional factors and 10% bovine serum.

[0038] The basic culture medium is Advanced DME / F12.

[0039] The culture factors include the following components and their contents: 1×GlutaMax, 1×HEPES, 1×P / S, 10%RSPO-1, 10%Noggin, 1×B27, 450ng / mLNA, 4mMN-acetylcysteine, 2nMgastrin, 5μM A83-01, 16μMY-27632 and 5g / μLprimocin, 1×insulin.

[0040] The nutritional factors include the following components and their contents: 50% Wnt3a, 65 ng / mL EGF, 350 ng / mL FGF10, 470 ng / mL BFGF, 10% RSPO-1, and 360 ng / mL BDNF.

[0041] The pH value of the culture medium is 8.2.

[0042] Example 4

[0043] A culture medium and a culture method for gastric cancer organoids, the culture method comprising the following steps: Step 1: Liquid preparation Prepare digestion solution: add 6 mg collagenase and 200 μg hyaluronidase into 10 mL basal medium.

[0044] Prepare complete culture medium: add 140 μL culture factor and 100 μL nutrient factor 10% bovine serum to 9.76 mL basal culture medium, and the ingredients and contents thereof follow the formula of implementation 1.

[0045] Step 2 Separation Gastric cancer biopsy tissue was stored in Advanced DME / F12 solution containing 2% double antibody for further processing.

[0046] Take the biopsy tissue, confirm that the epithelium is pure, wash it with basal culture medium and cut it into small pieces (1-3mm³). Put it into the digestion solution and digest it at 37℃ for 30 minutes. After digestion, dilute it with PBS and filter it, centrifuge it to remove impurities and red blood cells, and wash the precipitate with basal culture medium several times until it is clear.

[0047] Mix the cells with the matrix gel according to the cell concentration (10,000 cells / 25 μL matrix gel), add 30 μL to each well of a 24-well plate, and let it stand for 20 minutes to solidify. Then, slowly add 500 μL of complete medium to each well and place it in a CO2 incubator. Monitor and replace part of the complete medium every 2-3 days. It is expected that gastric cancer cells will be generated within 7-10 days.

[0048] Step 3: Primary culture Gastric cancer cells were taken from a centrifuge tube, rinsed twice with PBS, and then digested with trypsin digestion solution for 2-3 minutes. After the digestion reaction, the centrifuge tube was centrifuged at 1200rpm for 3 minutes, the supernatant was removed, and the cells were inoculated in a culture flask with complete culture medium. The culture conditions were 37°C and 5% CO2 for 4-5 days to obtain primary gastric cancer cells. The cell status was observed under a microscope as shown in the figure below. Figure 1-4 Shown Step 4: Subculture Take the cultured cells from the centrifuge tube, repeat the above step 3, and subculture for 4 generations to obtain a sufficient number of gastric cancer cell subculture cells that maintain a good growth state for further experiments or research.

[0049] Example 5

[0050] The complete medium prepared in this example is as follows: 140 μL of culture factors, 100 μL of nutrient factors and 10% bovine serum are added to 9.76 mL of basal medium, and its components and contents follow the formula of Example 2. The remaining steps of the gastric cancer organoid culture method are the same as those of Example 4.

[0051] Example 6

[0052] The complete medium prepared in this example is as follows: 140 μL of culture factors, 100 μL of nutrient factors and 10% bovine serum are added to 9.76 mL of basal medium, and its components and contents follow the formula of Example 3. The remaining steps of the gastric cancer organoid culture method are the same as those of Example 4.

[0053] Comparative Example 1 The complete culture medium of this comparative example was prepared by adding 240 μL of culture factors and 10% bovine serum to 9.76 mL of basal culture medium, and the culture factor components and their contents followed the formula of Example 1. The remaining steps of the gastric cancer organoid culture method were the same as those of Example 4.

[0054] When analyzing the results of immunofluorescence detection of cultured cells, we need to comprehensively consider data from multiple aspects, including but not limited to the survival rate of gastric cancer cells, the proportion of immunofluorescence positive cells, the expression intensity of the target protein, and the possible performance of the control group, to comprehensively evaluate the differences and effects between different embodiments and comparative examples.

[0055] Table 1: Examples and comparative examples data; Example / Comparative Example Gastric cancer cell survival rate (%) Immunofluorescence positive cell ratio (%) Example 4 98 90 Example 5 94 85 Example 6 95 87 Comparative Example 85 70 Table 1 shows that Example 4 has the highest gastric cancer cell survival rate, reaching 98%, and also has excellent immunofluorescence positive cell ratio and target protein expression intensity results, indicating that the culture conditions in this example are most conducive to the growth and survival of gastric cancer cells and significantly promote the expression of the target protein.

[0056] The survival rates of Examples 5 and 6 gradually decreased, but still remained at a relatively high level, indicating that although these conditions were not as good as those of Example 4, they could also effectively support the growth of gastric cancer cells.

[0057] The control group had the lowest survival rate of only 85%, indicating that the basic culture conditions were challenging for maintaining the long-term survival of gastric cancer cells.

[0058] In summary, the culture medium of the present invention shows significant advantages in terms of gastric cancer cell survival rate, morphology maintenance and target protein expression, and is the most ideal gastric cancer cell culture scheme in the present invention. By fine-tuning the culture conditions, the cell culture effect can be improved to a certain extent. The results of the comparative example emphasize the necessity of optimizing the culture medium in practical applications to ensure the stable growth and efficient expression of gastric cancer cells.

[0059] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A culture medium and a culture method for gastric cancer organoids, characterized in that: The culture medium comprises: basic culture medium, culture factors, nutrition factors and 10% bovine serum.

2. A culture medium and a culture method for gastric cancer organoids according to claim 1, characterized in that: The culture factors include the following components and their contents: 1-3×GlutaMax, 1-3×HEPES, 1-3×P / S, 5-10%Noggin, 1-3×B27, 300-500ng / mLNA, 1-5mMN-acetylcysteine, 1-3nMgastrin, 2-6μMA83-01, 7-16μMY-27632, 1-6g / μLprimocin, and 1-3×insulin.

3. The culture medium and culture method of gastric cancer organoids according to claim 1, characterized in that: The nutritional factors include the following components and their contents: 30-70% Wnt3a, 30-70ng / mL EGF, 100-500 ng / mL FGF10, 300-500ng / mL BFGF, 5-15% RSPO-1, and 300-500ng / mL BDNF.

4. The culture medium and culture method of gastric cancer organoids according to claim 1, characterized in that: The pH value of the culture medium is 8.0-8.5.

Citation Information

Cited By

  • Construction method and application of gastric cancer treatment effect evaluation model of CAR-T cells

    CN119899805A